Table 3.

Association between facility characteristics and the provision of timely and appropriate empiric antibiotics for neonatal sepsis (adjusted OR (95% CI))

	All cases (n=821)	Cases seen at facilities included at both baseline and follow-up (n=616)	Cases seen at complete-level facilities only (n=622)
Complete-level facility	0.68 (0.23 to 2.02)	0.26 (0.05 to 1.29)	Omitted
Country
Belize	0.99 (0.57 to 1.73)	0.90 (0.46 to 1.79)	0.94 (0.57 to 1.55)
Guatemala	0.39 (0.20 to 0.77)	0.42 (0.19 to 0.94)	0.37 (0.18 to 0.76)
Honduras	Ref	Ref	Ref
Mexico	0.13 (0.06 to 0.30)	0.11 (0.04 to 0.31)	0.08 (0.02 to 0.26)
Nicaragua	0.18 (0.05 to 0.60)	0.05 (0.01 to 0.29)	0.04 (0.00 to 0.35)
Paediatrician on staff	3.19 (0.40 to 25.76)	1.16 (0.21 to 6.56)	0.54 (0.17 to 1.78)
Relevant training* within prior 12 months	0.57 (0.26 to 1.24)	0.51 (0.19 to 1.34)	0.43 (0.18 to 1.06)
Availability of appropriate antibiotic combination	5.36 (2.85 to 10.08)	7.40 (3.01 to 18.15)	6.95 (2.66 to 18.16)
18-month follow-up	0.32 (0.15 to 0.68)	0.27 (0.09 to 0.81)	0.26 (0.09 to 0.78)

*Relevant training includes IMCI/AIEPI/management of neonatal complications.

IMCI, integrated management of childhood illnesses.